CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $213,000 | -88.2% | 16,609 | -93.6% | 0.18% | -87.7% |
| Q2 2022 | $1,806,000 | -15.6% | 257,621 | -0.2% | 1.43% | -4.3% |
| Q1 2022 | $2,139,000 | +20.8% | 258,073 | -1.3% | 1.50% | +6.9% |
| Q4 2021 | $1,770,000 | +24.9% | 261,403 | -2.3% | 1.40% | +20.3% |
| Q3 2021 | $1,417,000 | -3.9% | 267,437 | +4.2% | 1.16% | -7.7% |
| Q2 2021 | $1,475,000 | +25.3% | 256,566 | +0.5% | 1.26% | +16.7% |
| Q1 2021 | $1,177,000 | +65.1% | 255,266 | +19.6% | 1.08% | +48.4% |
| Q4 2020 | $713,000 | – | 213,432 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |